TELA Bio Inc Ordinary Shares TELA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.72
- Day Range
- $0.72–0.74
- 52-Week Range
- $0.50–2.19
- Bid/Ask
- $0.71 / $0.74
- Shares Outstanding
- 44.77M
- Market Cap
- $32.25M
- Volume/Avg
- 20,091 / 153,383
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.45
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 218
- Website
- https://www.telabio.com
Valuation
|
Metric
|
TELA
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.45 |
Price/Cash Flow | — |
Price/Earnings
TELA
Financial Strength
|
Metric
|
TELA
|
|---|---|
Quick Ratio | 2.76 |
Current Ratio | 3.61 |
Interest Coverage | −5.51 |
Quick Ratio
TELA
Profitability
|
Metric
|
TELA
|
|---|---|
Return on Assets (Normalized) | −50.77% |
Return on Equity (Normalized) | −605.81% |
Return on Invested Capital (Normalized) | −58.74% |
Return on Assets
TELA
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|h#Mw@# | LOCK|cRk@ | $177B | |||
| Stryker Corp
SYK
| LOCK|!?CmxsJ | LOCK|<TB | $122B | |||
| Medtronic PLC
MDT
| LOCK|&^?$?j | LOCK|Fpj%# | $107B | |||
| Boston Scientific Corp
BSX
| LOCK|$!H#TD | LOCK|<B&M@ | $65B | |||
| Edwards Lifesciences Corp
EW
| LOCK|<NrFNcM | LOCK|jY&N | $49B | |||
| DexCom Inc
DXCM
| LOCK|GdvW!><C | LOCK|SRk#y | $29B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|@>q%%# | LOCK|j$z | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|R>L | LOCK|?# | $26B | |||
| Steris PLC
STE
| LOCK|HqmJR>@ | LOCK|JB$Qw | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|$$<<ZBY | LOCK|Q%X | $17B |
United States